Results 101 to 110 of about 10,569 (220)

Urinary glycosaminoglycan levels in patients with Graves' opthalmopathy: An effective parameter for the grading of ophthalmopathy

, 1996
An increased accumulation of glycosaminoglycans (GAGs) in retrobulbar tissues has been reported in patients with Graves' ophthalmopathy (GO). We examined quantitative urinary GAGs excretion in patients with different grades of GO. 36 patients with Graves'
Ademoglu, Evin, Gokkusu, CAHİDE, Yarman, S, Turkoglu, UM, Alagol, F   +4 more
core  

Plasma exchange therapy for severe graves' ophthalmopathy

, 1986
In the present studies, the authors report on the treatment of nine Graves' disease patients with severe ophthalmopathy by use of intensive plasma exchange followed by immunosuppression (during three to six months). Results of treatment were evaluated by
Winand, René, Schrooyen, Marc, Glinoer, Daniel   +2 more
core   +1 more source

Infliximab: a novel treatment for sight threatening thyroid associated ophthalmopathy

, 2005
We describe a patient with sight threatening thyroid associated ophthalmopathy (TAO) who was successfully treated with infliximab, an anti-tumour necrosis factor (TNF)-a ...
Reuser, Tristan, Murray, Philip; id_orcid, Durrani, Omar   +2 more
core   +1 more source

Immunopathogenesis of Graves\u27 Ophthalmopathy

, 1984
Clinical Background. Course of Ophthalmopathy. This may occur at any time in relation to thyrotoxicosis and myoxedema. May improve, worsen, or not change with thyrotoxicosis management, and its uncertain relationship to medical, radioactive iodine, and ...
Robert C. Sergott
core  

Pathogenesis of Graves’ Ophthalmopathy [PDF]

International Archives of Allergy and Immunology, 2009
C, Spitzweg, A E, Heufelder
openaire   +2 more sources

A case of pretibial myxedema treated with teprotumumab

JAAD Case Reports, 2021
Lauren Petit, MD, Anna Catinis, BA, Emily Richard, MD, Joel Silverberg, MD   +3 more
doaj   +1 more source

[The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].

, 1992
The most frequently used medical treatment of Graves' ophthalmopathy is the combination of orbital irradiation and systemic corticosteroid. In this study the effectiveness of "high dose intravenous immunoglobulin" (IVIG) in Graves' ophthalmopathy ...
Alberti B, Baschieri L., ANTONELLI, ALESSANDRO, Lepri A, Saracino A, Laddaga M, Melosi A, Cartei F   +7 more
core  

Systemic Inflammatory Markers, Thyroid Autoimmunity, and Neuroretinal Structure in Graves' Disease: A Comparative OCT Study According to Ophthalmopathy Status. [PDF]

Metabolites
Keser S, Bulu A.
europepmc   +1 more source

Unilateral Thyroid Associated Ophthalmopathy

, 1998
At present, no laboratory test or clinical finding pathognomic for Thyroid Associated Ophthalmopathy (TAO) are currently recognized. The recognized clinical diagnostic criteria for TAO are: eyelid retraction or not, exophthalmos, optic nerve dysfunction,
Antonella Boschi, MD; S. Bianchi-Marzoli, MD; C. Kolanowski, MD; C. Sannace, MD; R. Brancato, MD; M. C. Manie, MD; C. Daumerie, MD
core  

Association between serum immunoglobulin G4 levels and Graves' ophthalmopathy: a meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Zhang R, Huo Y, Guo Y, Li J, Du A.
europepmc   +1 more source